|
Mar 19
|
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
|
|
Mar 19
|
AstraZeneca (AZN): Among the Best Diabetes Stocks to Buy According to Billionaires
|
|
Mar 19
|
3 UK Stocks Estimated To Be Trading At Discounts Of Up To 48.5%
|
|
Mar 18
|
Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?
|
|
Mar 18
|
AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
|
|
Mar 18
|
Stoke CEO exits; Medicare drug price talks advance
|
|
Mar 18
|
AstraZeneca and Alteogen agree on ALT-B4 platform tech
|
|
Mar 17
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Mar 17
|
European Equities Rise in Monday Trading; AstraZeneca to Acquire EsoBiotec for Up to $1 Billion
|
|
Mar 17
|
AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer
|
|
Mar 17
|
AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies
|
|
Mar 17
|
IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
|
|
Mar 17
|
Eventful Monday For AstraZeneca - What's Going On?
|
|
Mar 17
|
Trending tickers: Nvidia, Berkshire Hathaway, Baidu, QinetiQ and AstraZeneca
|
|
Mar 17
|
AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec
|
|
Mar 17
|
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
|
|
Mar 17
|
AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio
|
|
Mar 17
|
AstraZeneca to buy EsoBiotec for up to $1 billion
|
|
Mar 17
|
EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition
|
|
Mar 14
|
AstraZeneca Stock Scores RS Rating Upgrade
|